Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Paul Maroni

Concepts (351)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Prostatic Neoplasms
39
2024
1044
3.810
 Why?
Prostatectomy
8
2019
102
1.500
 Why?
Testicular Neoplasms
7
2023
115
1.100
 Why?
Urology
3
2020
61
0.850
 Why?
Embolism
1
2021
43
0.690
 Why?
Urethra
1
2021
54
0.690
 Why?
Neoplasms, Germ Cell and Embryonal
3
2023
78
0.680
 Why?
Androgen Antagonists
4
2024
93
0.670
 Why?
Laser Therapy
1
2021
127
0.620
 Why?
Clinical Trials as Topic
1
2020
1034
0.470
 Why?
Kidney Medulla
2
2005
31
0.460
 Why?
Early Detection of Cancer
5
2023
426
0.420
 Why?
Neoadjuvant Therapy
2
2021
412
0.370
 Why?
Urination Disorders
1
2011
14
0.360
 Why?
Prostate-Specific Antigen
8
2020
165
0.360
 Why?
Male
56
2024
68260
0.350
 Why?
Prostate
7
2023
173
0.330
 Why?
Oxalates
2
2008
11
0.310
 Why?
Randomized Controlled Trials as Topic
2
2014
1518
0.280
 Why?
Neoplasm Grading
5
2021
305
0.280
 Why?
Adenocarcinoma
3
2022
885
0.270
 Why?
Radiotherapy, Adjuvant
2
2018
215
0.260
 Why?
Humans
59
2024
138651
0.260
 Why?
Neoplasm Staging
7
2021
1372
0.240
 Why?
Kidney Tubules, Collecting
1
2005
27
0.230
 Why?
Oxalic Acid
1
2004
4
0.230
 Why?
Brachytherapy
2
2016
129
0.220
 Why?
Clinical Competence
1
2012
1149
0.220
 Why?
Urinary Bladder Neoplasms
2
2021
254
0.210
 Why?
Androgens
4
2024
186
0.190
 Why?
Paraganglioma
1
2022
53
0.180
 Why?
Cell Hypoxia
2
2015
230
0.180
 Why?
Adrenal Gland Neoplasms
1
2022
88
0.180
 Why?
Cation Transport Proteins
1
2022
109
0.170
 Why?
Prolactin
3
1997
96
0.170
 Why?
Surveys and Questionnaires
3
2017
5803
0.170
 Why?
Adaptor Proteins, Vesicular Transport
2
1997
46
0.170
 Why?
Aged
21
2021
24024
0.170
 Why?
Orchiectomy
3
2016
75
0.160
 Why?
Magnetic Resonance Imaging, Interventional
1
2020
26
0.160
 Why?
Middle Aged
20
2021
33604
0.160
 Why?
Risk Assessment
4
2020
3433
0.160
 Why?
Salvage Therapy
2
2018
151
0.160
 Why?
Stromal Cells
1
2019
112
0.150
 Why?
Proanthocyanidins
1
2019
9
0.150
 Why?
Biflavonoids
1
2019
9
0.150
 Why?
Catechin
1
2019
25
0.150
 Why?
Euterpe
1
2018
4
0.150
 Why?
Anthocyanins
1
2019
32
0.150
 Why?
Hospitals
2
2023
695
0.150
 Why?
Grape Seed Extract
1
2019
43
0.150
 Why?
Nomograms
1
2019
54
0.140
 Why?
Digital Rectal Examination
1
2018
10
0.140
 Why?
Reagent Kits, Diagnostic
1
2018
35
0.140
 Why?
Neoplasm Recurrence, Local
2
2018
1057
0.140
 Why?
Adaptor Proteins, Signal Transducing
2
1997
428
0.140
 Why?
Antineoplastic Agents, Phytogenic
1
2019
190
0.140
 Why?
Mitogen-Activated Protein Kinase Kinases
1
1997
132
0.130
 Why?
Urinary Tract Infections
1
2019
193
0.130
 Why?
Proton Therapy
1
2017
14
0.130
 Why?
Biopsy, Needle
2
2016
187
0.130
 Why?
Surgical Wound Infection
2
2019
313
0.130
 Why?
Seminoma
1
2017
20
0.130
 Why?
Sertoli-Leydig Cell Tumor
1
2016
8
0.130
 Why?
Neoplasm Metastasis
5
2019
666
0.130
 Why?
Plant Extracts
1
2018
207
0.130
 Why?
Radiology
1
2019
164
0.130
 Why?
Liver
4
1997
1805
0.120
 Why?
Medical Oncology
1
2019
304
0.120
 Why?
Spectrum Analysis
1
2016
91
0.120
 Why?
Sex Cord-Gonadal Stromal Tumors
1
2015
5
0.120
 Why?
Prognosis
7
2019
3984
0.120
 Why?
Radiotherapy, Conformal
1
2015
73
0.120
 Why?
Proto-Oncogene Proteins
2
1997
620
0.110
 Why?
Risk
2
2015
893
0.110
 Why?
Lymphatic Metastasis
3
2014
323
0.110
 Why?
Neoplastic Stem Cells
1
2019
396
0.110
 Why?
HSP70 Heat-Shock Proteins
2
2008
74
0.110
 Why?
Fluorodeoxyglucose F18
1
2015
144
0.110
 Why?
Biopsy
4
2023
1072
0.110
 Why?
Genomics
1
2019
796
0.110
 Why?
Leydig Cell Tumor
1
2014
8
0.110
 Why?
Cause of Death
1
2016
433
0.110
 Why?
Receptors, Adrenergic, alpha
1
2013
21
0.100
 Why?
Priapism
1
2013
11
0.100
 Why?
Hypertension
1
2022
1242
0.100
 Why?
Adrenergic alpha-Antagonists
1
2013
34
0.100
 Why?
Optics and Photonics
1
2014
42
0.100
 Why?
Cytochrome P-450 CYP3A Inhibitors
1
2013
18
0.100
 Why?
Spectrometry, Fluorescence
1
2014
167
0.100
 Why?
Extracellular Vesicles
1
2015
148
0.100
 Why?
Triglycerides
1
2015
513
0.100
 Why?
Proline
1
2013
76
0.100
 Why?
Treatment Outcome
7
2018
10923
0.100
 Why?
Matrix Metalloproteinase 9
2
2010
133
0.100
 Why?
Neoplasm Invasiveness
4
2016
501
0.090
 Why?
Drug Interactions
1
2013
404
0.090
 Why?
Telephone
1
2013
180
0.090
 Why?
Cardiovascular Diseases
1
2024
2053
0.090
 Why?
Signal Transduction
4
2004
5086
0.090
 Why?
Survival Rate
4
2017
1935
0.090
 Why?
Urothelium
1
2011
37
0.090
 Why?
Cell Line
3
2008
2876
0.090
 Why?
Lymph Nodes
1
2014
492
0.090
 Why?
Prostatic Hyperplasia
1
2011
41
0.090
 Why?
Neoplastic Cells, Circulating
1
2011
76
0.080
 Why?
Attitude of Health Personnel
1
2019
1157
0.080
 Why?
Mitogen-Activated Protein Kinase 1
4
2008
183
0.080
 Why?
Spinal Fractures
1
2011
74
0.080
 Why?
Epithelial Cells
2
2008
1102
0.080
 Why?
Carcinogenesis
2
2022
215
0.080
 Why?
Oxygen
1
2015
977
0.080
 Why?
Aged, 80 and over
6
2020
7677
0.080
 Why?
Proto-Oncogene Proteins c-ets
1
2010
56
0.080
 Why?
Combined Modality Therapy
2
2016
1235
0.080
 Why?
Survival Analysis
2
2016
1309
0.080
 Why?
Glucose
1
2015
1032
0.080
 Why?
Postoperative Complications
2
2019
2722
0.080
 Why?
Counseling
1
2013
392
0.080
 Why?
p38 Mitogen-Activated Protein Kinases
2
2009
280
0.080
 Why?
Mitogen-Activated Protein Kinase 3
3
2008
150
0.080
 Why?
Decision Making
1
2017
948
0.080
 Why?
Lymph Node Excision
2
2014
168
0.080
 Why?
Carcinoma
1
2011
229
0.080
 Why?
Survivors
1
2013
498
0.080
 Why?
Lymphatic Diseases
1
2009
22
0.080
 Why?
Cystitis
1
2009
23
0.070
 Why?
Focal Adhesion Protein-Tyrosine Kinases
1
2008
35
0.070
 Why?
Age Factors
4
2017
3256
0.070
 Why?
Logistic Models
3
2019
2065
0.070
 Why?
Patient Selection
2
2018
676
0.070
 Why?
Neoplasms, Hormone-Dependent
1
2008
38
0.070
 Why?
Patient Education as Topic
1
2013
766
0.070
 Why?
Proportional Hazards Models
3
2016
1229
0.070
 Why?
Databases, Factual
3
2019
1415
0.070
 Why?
Cell Line, Tumor
5
2015
3392
0.070
 Why?
Image-Guided Biopsy
2
2020
39
0.070
 Why?
Societies, Medical
1
2011
839
0.060
 Why?
Adult
12
2020
38201
0.060
 Why?
Antineoplastic Agents, Hormonal
1
2008
168
0.060
 Why?
Hypoxia-Inducible Factor 1, alpha Subunit
1
2009
285
0.060
 Why?
Diagnostic Imaging
2
2022
320
0.060
 Why?
Kidney Tubules, Proximal
1
2008
132
0.060
 Why?
Time Factors
4
2014
6851
0.060
 Why?
Calcium-Calmodulin-Dependent Protein Kinases
2
1997
174
0.060
 Why?
Chemotherapy, Adjuvant
1
2008
375
0.060
 Why?
Radiotherapy Dosage
2
2018
281
0.060
 Why?
Reactive Oxygen Species
2
2009
624
0.060
 Why?
Animals
11
2022
37217
0.060
 Why?
Follow-Up Studies
4
2016
5112
0.060
 Why?
Oxidative Stress
2
2010
1316
0.060
 Why?
Young Adult
6
2020
13305
0.060
 Why?
Isoflavones
1
2005
26
0.060
 Why?
Ear, Inner
1
2005
49
0.060
 Why?
Support Vector Machine
2
2016
37
0.060
 Why?
Mitotic Index
2
2015
24
0.060
 Why?
History, 21st Century
1
2006
214
0.060
 Why?
Mice
4
2022
17814
0.060
 Why?
Body Fluids
1
2005
70
0.060
 Why?
Cell Count
1
2005
325
0.060
 Why?
Urinary Incontinence
1
2005
65
0.060
 Why?
Growth
1
2004
51
0.050
 Why?
Disease Progression
2
2018
2749
0.050
 Why?
Informed Consent
1
2006
188
0.050
 Why?
Kidney Neoplasms
1
2009
393
0.050
 Why?
MAP Kinase Signaling System
2
2008
322
0.050
 Why?
Propensity Score
2
2016
316
0.050
 Why?
United States
5
2019
14938
0.050
 Why?
Mass Screening
2
2015
1292
0.050
 Why?
Cell Proliferation
3
2019
2480
0.050
 Why?
Multivariate Analysis
2
2017
1482
0.050
 Why?
Receptors, Nicotinic
1
2005
344
0.050
 Why?
Protein-Tyrosine Kinases
2
1997
431
0.050
 Why?
Kaplan-Meier Estimate
2
2016
896
0.050
 Why?
Transcriptional Regulator ERG
1
2022
17
0.050
 Why?
Urinary Bladder
1
2004
187
0.050
 Why?
Antineoplastic Agents
1
2013
2152
0.050
 Why?
Sensitivity and Specificity
3
2016
1941
0.050
 Why?
Rats, Wistar
3
1997
453
0.040
 Why?
Rats
6
2005
5594
0.040
 Why?
Serine Endopeptidases
1
2022
119
0.040
 Why?
Intestines
1
2004
356
0.040
 Why?
Cell Survival
2
2019
1123
0.040
 Why?
Src Homology 2 Domain-Containing, Transforming Protein 1
2
1997
12
0.040
 Why?
Shc Signaling Adaptor Proteins
2
1997
12
0.040
 Why?
Testosterone
2
2015
402
0.040
 Why?
Gene Expression Regulation, Enzymologic
1
2001
274
0.040
 Why?
Hyperthermia, Induced
1
2001
120
0.040
 Why?
Biomarkers, Tumor
2
2020
1224
0.040
 Why?
Oncogene Proteins, Fusion
1
2022
203
0.040
 Why?
Adolescent
5
2022
21564
0.040
 Why?
Fever
1
2001
305
0.040
 Why?
Cerebellum
1
2001
218
0.040
 Why?
Cell Transformation, Neoplastic
1
2022
333
0.040
 Why?
Reperfusion
2
1996
44
0.040
 Why?
Inflammation
1
2010
2850
0.040
 Why?
Mitogen-Activated Protein Kinases
2
2001
316
0.040
 Why?
Feeding Behavior
1
2005
674
0.040
 Why?
Jagged-1 Protein
1
2019
23
0.040
 Why?
Retrospective Studies
4
2023
15909
0.040
 Why?
Geography
1
2019
200
0.040
 Why?
Fruit and Vegetable Juices
1
2018
16
0.040
 Why?
Receptor, Notch1
1
2019
65
0.040
 Why?
Zinc
1
2022
298
0.040
 Why?
Positron Emission Tomography Computed Tomography
1
2019
104
0.040
 Why?
Tissue Kallikreins
1
2018
2
0.040
 Why?
Radiometry
1
2018
50
0.040
 Why?
Spheroids, Cellular
1
2019
75
0.040
 Why?
Quality of Life
2
2013
2954
0.040
 Why?
Stress, Physiological
1
2001
450
0.040
 Why?
Enzyme Activation
4
2008
810
0.040
 Why?
Kallikreins
1
2018
27
0.040
 Why?
Janus Kinase 2
1
1997
32
0.030
 Why?
Enzyme Induction
1
1997
90
0.030
 Why?
Carrier Proteins
1
2022
737
0.030
 Why?
Cells, Cultured
1
2005
4181
0.030
 Why?
MAP Kinase Kinase 1
1
1997
75
0.030
 Why?
Radiotherapy, Intensity-Modulated
1
2018
137
0.030
 Why?
Tumor Cells, Cultured
1
2019
956
0.030
 Why?
National Cancer Institute (U.S.)
1
2017
48
0.030
 Why?
Phosphorylation
4
2008
1760
0.030
 Why?
Health Care Surveys
1
2019
565
0.030
 Why?
Phenotype
3
2010
3139
0.030
 Why?
Prospective Studies
2
2020
7554
0.030
 Why?
Protein Kinase C
2
1994
252
0.030
 Why?
Ultrasonography
1
2020
745
0.030
 Why?
Feminization
1
2015
6
0.030
 Why?
Epoxy Compounds
1
2015
31
0.030
 Why?
Carnitine O-Palmitoyltransferase
1
2015
45
0.030
 Why?
Altitude
1
2019
467
0.030
 Why?
Heterografts
1
2015
135
0.030
 Why?
Environmental Exposure
1
2019
565
0.030
 Why?
Female
7
2021
73763
0.030
 Why?
Ischemia
2
1996
414
0.030
 Why?
Proteins
2
1997
1006
0.030
 Why?
Disease-Free Survival
1
2016
704
0.030
 Why?
T-Lymphocytes, Helper-Inducer
1
1995
136
0.030
 Why?
Cell Movement
1
2019
969
0.030
 Why?
Colorado
2
2015
4555
0.030
 Why?
Least-Squares Analysis
1
2014
78
0.030
 Why?
Immunohistochemistry
2
2010
1731
0.030
 Why?
Positron-Emission Tomography
1
2015
304
0.030
 Why?
Mice, Nude
1
2015
688
0.030
 Why?
Needles
1
2014
62
0.030
 Why?
Risk Factors
2
2019
10252
0.030
 Why?
SEER Program
1
2014
220
0.020
 Why?
Radiotherapy
1
2014
207
0.020
 Why?
Cytochrome P-450 CYP3A
1
2013
89
0.020
 Why?
Aging
3
2010
1855
0.020
 Why?
T-Lymphocyte Subsets
1
1995
415
0.020
 Why?
Estrogens
1
2015
365
0.020
 Why?
T-Lymphocytes, Regulatory
1
1995
386
0.020
 Why?
Equipment Design
1
2014
519
0.020
 Why?
Child
3
2022
21921
0.020
 Why?
Lipid Metabolism
1
2015
522
0.020
 Why?
Oxidation-Reduction
1
2015
1076
0.020
 Why?
Reoperation
1
2014
579
0.020
 Why?
Population Surveillance
1
2014
476
0.020
 Why?
Life Style
1
2013
478
0.020
 Why?
In Situ Hybridization, Fluorescence
1
2011
310
0.020
 Why?
Cell Separation
1
2011
317
0.020
 Why?
Atrophy
1
2010
189
0.020
 Why?
Apoptosis
1
2019
2546
0.020
 Why?
Microscopy, Fluorescence
1
2011
414
0.020
 Why?
Anxiety
1
2017
1072
0.020
 Why?
Cohort Studies
1
2020
5697
0.020
 Why?
DNA Primers
1
2010
508
0.020
 Why?
Nephrolithiasis
1
2009
10
0.020
 Why?
JNK Mitogen-Activated Protein Kinases
2
2001
159
0.020
 Why?
Prostatitis
1
2009
18
0.020
 Why?
Metaplasia
1
2009
58
0.020
 Why?
Feasibility Studies
1
2013
980
0.020
 Why?
Tumor Stem Cell Assay
1
2008
34
0.020
 Why?
Incidence
1
2015
2747
0.020
 Why?
Imaging, Three-Dimensional
1
2012
564
0.020
 Why?
Social Support
1
2013
625
0.020
 Why?
Anoikis
1
2008
31
0.020
 Why?
Socioeconomic Factors
1
2013
1296
0.020
 Why?
NADPH Oxidases
1
2009
140
0.020
 Why?
Genes, Immediate-Early
1
2008
25
0.020
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2010
984
0.020
 Why?
Immunoblotting
2
2001
309
0.020
 Why?
Magnetic Resonance Imaging
1
2020
3637
0.020
 Why?
Proto-Oncogene Proteins c-jun
1
2008
57
0.020
 Why?
Adaptation, Psychological
1
2013
673
0.020
 Why?
Practice Patterns, Physicians'
1
2017
1323
0.020
 Why?
Tyrosine
2
2001
227
0.020
 Why?
Receptors, Androgen
1
2009
150
0.020
 Why?
Gonadal Steroid Hormones
1
2009
138
0.020
 Why?
Blotting, Western
1
2010
1230
0.020
 Why?
Pilot Projects
1
2013
1765
0.020
 Why?
DNA, Mitochondrial
1
2009
208
0.020
 Why?
RNA, Messenger
2
2008
2815
0.020
 Why?
Glutathione
1
2009
355
0.020
 Why?
Base Sequence
1
2010
2174
0.020
 Why?
Proto-Oncogene Proteins c-myc
1
2008
147
0.020
 Why?
RNA, Small Interfering
1
2008
626
0.020
 Why?
Phosphotyrosine
2
1996
40
0.020
 Why?
Hypoglycemic Agents
1
2015
1341
0.020
 Why?
Models, Animal
1
2008
395
0.020
 Why?
Chinchilla
1
2005
34
0.010
 Why?
Equol
1
2005
5
0.010
 Why?
Guinea Pigs
1
2005
170
0.010
 Why?
Swine
1
2008
801
0.010
 Why?
Antioxidants
1
2009
593
0.010
 Why?
Bladder Exstrophy
1
2004
17
0.010
 Why?
Acid-Base Equilibrium
1
2004
25
0.010
 Why?
Stress, Psychological
1
2013
1119
0.010
 Why?
Diagnosis, Differential
1
2009
1482
0.010
 Why?
Bicarbonates
1
2004
45
0.010
 Why?
Biomarkers
1
2015
4092
0.010
 Why?
Meat
1
2005
93
0.010
 Why?
Infant, Newborn
1
2015
6144
0.010
 Why?
Meningomyelocele
1
2004
59
0.010
 Why?
Body Height
1
2004
196
0.010
 Why?
Tomography, X-Ray Computed
1
2014
2698
0.010
 Why?
Hypoxia
1
2010
1149
0.010
 Why?
Referral and Consultation
1
2009
793
0.010
 Why?
Receptor, IGF Type 1
1
2001
64
0.010
 Why?
Infant
1
2015
9574
0.010
 Why?
Child, Preschool
1
2015
11158
0.010
 Why?
Bone Density
1
2004
489
0.010
 Why?
Animals, Newborn
1
2001
859
0.010
 Why?
Gene Expression Regulation
1
2008
2590
0.010
 Why?
ErbB Receptors
1
2001
609
0.010
 Why?
Neoplasms
1
2013
2681
0.010
 Why?
Mutation
1
2009
3987
0.010
 Why?
GRB2 Adaptor Protein
1
1996
13
0.010
 Why?
Proto-Oncogene Proteins c-raf
1
1996
44
0.010
 Why?
Neurons
1
2005
1601
0.010
 Why?
Sialoglycoproteins
1
1996
159
0.010
 Why?
Rats, Sprague-Dawley
1
2001
2499
0.010
 Why?
Receptors, Interleukin-1
1
1996
215
0.010
 Why?
Interleukin 1 Receptor Antagonist Protein
1
1996
255
0.010
 Why?
Lymphocyte Count
1
1995
166
0.010
 Why?
Phosphotransferases
1
1994
24
0.010
 Why?
Precipitin Tests
1
1994
98
0.010
 Why?
Densitometry
1
1994
38
0.010
 Why?
CD4 Lymphocyte Count
1
1995
280
0.010
 Why?
Injections, Intraperitoneal
1
1994
114
0.010
 Why?
Ornithine Decarboxylase
1
1994
13
0.010
 Why?
Genes, myc
1
1994
48
0.010
 Why?
Molecular Weight
1
1994
327
0.010
 Why?
Electrophoresis, Polyacrylamide Gel
1
1994
336
0.010
 Why?
Cytosol
1
1994
227
0.010
 Why?
Substrate Specificity
1
1994
383
0.010
 Why?
Kinetics
1
1996
1645
0.010
 Why?
Interleukin-1
1
1996
966
0.010
 Why?
Gene Expression
1
1994
1488
0.000
 Why?
Antibodies, Monoclonal
1
1994
1436
0.000
 Why?
T-Lymphocytes
1
1995
1986
0.000
 Why?
Maroni's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (351) concept(s)
_
Co-Authors Expand Description
See all (40) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)